Ramirez Asset Management Inc. Takes $40,000 Position in Danaher Corporation $DHR

Ramirez Asset Management Inc. bought a new stake in shares of Danaher Corporation (NYSE:DHR) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 200 shares of the conglomerate’s stock, valued at approximately $40,000.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. GHP Investment Advisors Inc. lifted its position in shares of Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after buying an additional 99 shares in the last quarter. Sierra Ocean LLC lifted its holdings in Danaher by 116.9% in the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 76 shares in the last quarter. Red Tortoise LLC lifted its holdings in Danaher by 175.0% in the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after purchasing an additional 98 shares in the last quarter. Smallwood Wealth Investment Management LLC purchased a new position in Danaher in the 1st quarter valued at $31,000. Finally, Dunhill Financial LLC lifted its holdings in Danaher by 68.4% in the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock valued at $34,000 after purchasing an additional 67 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Down 1.0%

Shares of DHR opened at $202.53 on Friday. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.41. The company has a market capitalization of $145.02 billion, a PE ratio of 43.09, a price-to-earnings-growth ratio of 2.91 and a beta of 0.77. The stock has a fifty day simple moving average of $200.66 and a two-hundred day simple moving average of $197.25. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. The firm had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company’s quarterly revenue was up 3.4% on a year-over-year basis. During the same period last year, the company earned $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is presently 27.23%.

Insider Activity

In related news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 11.10% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. UBS Group decreased their price objective on Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a report on Wednesday, July 23rd. Robert W. Baird raised their price objective on Danaher from $225.00 to $226.00 and gave the company an “outperform” rating in a report on Friday, July 18th. Rothschild & Co Redburn restated a “neutral” rating and issued a $220.00 price objective (down previously from $245.00) on shares of Danaher in a report on Wednesday. Rothschild Redb lowered Danaher from a “strong-buy” rating to a “hold” rating in a report on Wednesday. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Danaher in a report on Wednesday. Seventeen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $244.60.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.